Sesen Bio Inc. [NASDAQ: SESN] closed the trading session at $3.02 on 03/16/21. The day’s price range saw the stock hit a low of $2.82, while the highest price level was $3.07. The company report on March 15, 2021 that Sesen Bio Reports Fourth Quarter and Full-Year 2020 Financial Results and Significant Regulatory and Commercial Readiness Progress for the Company’s Lead Product Candidate Vicineum™.
Strengthened balance sheet: $98 million in cash and cash equivalents as of February 28, 20211.
Biologics License Application accepted by the FDA under Priority Review.
The stocks have a year to date performance of 123.70 percent and weekly performance of 11.85 percent. The stock has been moved at 190.38 percent over the last six months. The stock has performed 7.86 percent around the most recent 30 days and changed 80.84 percent over the most recent 3-months.
If compared to the average trading volume of 6.69M shares, SESN reached to a volume of 9220429 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Sesen Bio Inc. [SESN]:
H.C. Wainwright have made an estimate for Sesen Bio Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 11, 2019.
The Average True Range (ATR) for Sesen Bio Inc. is set at 0.29, with the Price to Sales ratio for SESN stock in the period of the last 12 months amounting to 40.71.
SESN stock trade performance evaluation
Sesen Bio Inc. [SESN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 11.85. With this latest performance, SESN shares gained by 7.86% in over the last four-week period, additionally plugging by 190.38% over the last 6 months – not to mention a rise of 563.74% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SESN stock in for the last two-week period is set at 63.73, with the RSI for the last a single of trading hit 66.76, and the three-weeks RSI is set at 62.97 for Sesen Bio Inc. [SESN]. The present Moving Average for the last 50 days of trading for this stock 2.25, while it was recorded at 2.81 for the last single week of trading, and 1.37 for the last 200 days.
Sesen Bio Inc. [SESN]: An insightful look at the core fundamentals
Return on Total Capital for SESN is now -421.21, given the latest momentum, and Return on Invested Capital for the company is -1,228.08. Return on Equity for this stock declined to -1,228.08, with Return on Assets sitting at -95.16.
Reflecting on the efficiency of the workforce at the company, Sesen Bio Inc. [SESN] managed to generate an average of -$4,300,000 per employee.Sesen Bio Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.10 and a Current Ratio set at 5.10.
Earnings per share (EPS) analysis for Sesen Bio Inc. [SESN] stock
With the latest financial reports released by the company, Sesen Bio Inc. posted 0.31/share EPS, while the average EPS was predicted by analysts to be reported at -0.09/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 444.40%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SESN.
Sesen Bio Inc. [SESN]: Insider Ownership positions
There are presently around $84 million, or 17.50% of SESN stock, in the hands of institutional investors. The top three institutional holders of SESN stocks are: VANGUARD GROUP INC with ownership of 5,893,620, which is approximately 25.393% of the company’s market cap and around 0.06% of the total institutional ownership; TRV GP, LLC, holding 4,841,591 shares of the stock with an approximate value of $14.62 million in SESN stocks shares; and RENAISSANCE TECHNOLOGIES LLC, currently with $8.79 million in SESN stock with ownership of nearly 44.33% of the company’s market capitalization.
Positions in Sesen Bio Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 31 institutional holders increased their position in Sesen Bio Inc. [NASDAQ:SESN] by around 5,536,841 shares. Additionally, 14 investors decreased positions by around 916,987 shares, while 14 investors held positions by with 21,211,388 shares. The mentioned changes placed institutional holdings at 27,665,216 shares, according to the latest SEC report filing. SESN stock had 14 new institutional investments in for a total of 1,534,297 shares, while 2 institutional investors sold positions of 215,818 shares during the same period.